Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Dividends declared (per SOCE filings): FY2022 421 · FY2023 70 · FY2024 0 — 3-yr total 491
Operates in Healthcare Services — Specialized medicine - private practice. Per the activity note to the FY2024 annual report, the company operates as a specialized fertility treatment and in vitro fertilization center.
| Line item | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|
| 6,852 | 15,167 | 3,026 | 4,782 | 8,846 | 13,795 | +12.4% | |
| 4,921 | 5,439 | 19,351 | 18,567 | 18,250 | 17,957 | +24.1% | |
| TOTAL ASSETS | 11,773 | 20,606 | 22,377 | 23,349 | 27,096 | 31,752 | +18.0% |
| 4,222 | 1,765 | 2,320 | 3,300 | 3,642 | 2,420 | -8.9% | |
| 1 | 10,045 | 11,716 | 8,319 | 4,812 | 1,344 | nmf | |
| TOTAL LIABILITIES | 4,220 | 11,810 | 14,036 | 11,619 | 8,454 | 3,764 | -1.9% |
| Total Equity | 7,553 | 8,796 | 8,341 | 11,730 | 18,642 | 27,988 | +24.4% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | |||||||
| Total Debt | 3,691 | 11,073 | 13,109 | 9,666 | 6,275 | 1,536 | -13.6% |
| Cash & Equivalents | 1,553 | 602 | 1,967 | 2,699 | 6,031 | 11,237 | +39.1% |
| Net Debt | 2,138 | 10,471 | 11,142 | 6,967 | 244 | 9,701 | nmf |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →